Veracyte, Inc.
VCYT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
VCYT Income Statement
VCYT Balance Sheet
VCYT Cash Flow
Recent trades of VCYT by members of U.S. Congress
VCYT Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
VCYT Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
VCYT Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by VCYT's directors and management
Government lobbying spending instances
-
$30,000 Apr 20, 2023 Issue: Health Issues
-
$30,000 Nov 17, 2022 Issue: Health Issues
-
$30,000 Jul 20, 2022 Issue: Health Issues
-
$30,000 Apr 20, 2022 Issue: Health Issues
-
$30,000 Jan 19, 2022 Issue: Health Issues
-
$30,000 Oct 15, 2021 Issue: Health Issues
-
$30,000 Jul 20, 2021 Issue: Health Issues
-
$30,000 Apr 13, 2021 Issue: Health Issues
-
$30,000 Jan 20, 2021 Issue: Health Issues
-
$30,000 Oct 06, 2020 Issue: Health Issues
-
$30,000 Jul 14, 2020 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 17, 2020 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Jan 21, 2020 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$30,000 Oct 21, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Jul 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Apr 22, 2019 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Oct 19, 2018 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Jul 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$30,000 Apr 20, 2018 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Jan 22, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$30,000 Oct 20, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$30,000 Apr 20, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Jan 24, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Oct 18, 2016 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$30,000 Jul 20, 2016 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$30,000 Apr 21, 2016 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Methods for classification of tissue samples as positive or negative for cancer Oct. 08, 2024
-
Patent Title: Methods and systems for detecting usual interstitial pneumonia May. 07, 2024
-
Patent Title: Methods for nucleic acid sequencing May. 02, 2023
-
Patent Title: Methods and systems for determining biological sample integrity Jan. 04, 2022
-
Patent Title: Methods and compositions for diagnosis of thyroid conditions Mar. 02, 2021
-
Patent Title: Algorithms for disease diagnostics Aug. 04, 2020
-
Patent Title: Algorithms for disease diagnostics Jun. 02, 2020
-
Patent Title: Methods for evaluating copd status Jan. 07, 2020
-
Patent Title: Methods and compositions for classification of samples Oct. 15, 2019
-
Patent Title: Methods for processing or analyzing a sample of thyroid tissue Mar. 19, 2019
-
Patent Title: Methods for processing or analyzing sample of thyroid tissue Oct. 30, 2018
-
Patent Title: Algorithms for disease diagnostics Jan. 02, 2018
-
Patent Title: Algorithms for disease diagnostics Nov. 15, 2016
-
Patent Title: Methods and compositions for diagnosis of thyroid conditions Mar. 11, 2014
-
Patent Title: Methods and compositions of molecular profiling for disease diagnostics Sep. 24, 2013
Government Contracts
Federal grants, loans, and purchases
- $19,392 2024-10-01 00:00:00 Agency: Department of Veterans Affairs
- $64,812 2024-10-01 00:00:00 Agency: Department of Veterans Affairs
- $70,000 2024-10-01 00:00:00 Agency: Department of Veterans Affairs
- $0 2024-09-17 00:00:00 Agency: Department of Veterans Affairs
- $0 2024-09-17 00:00:00 Agency: Department of Veterans Affairs
- $96,960 2024-09-01 00:00:00 Agency: Department of Veterans Affairs
- $56,000 2024-03-26 00:00:00 Agency: Department of Veterans Affairs
- $112,000 2024-03-26 00:00:00 Agency: Department of Veterans Affairs
- $84,000 2024-03-26 00:00:00 Agency: Department of Veterans Affairs
- $75,086 2024-03-14 00:00:00 Agency: Department of Veterans Affairs
- $96,960 2024-02-01 00:00:00 Agency: Department of Veterans Affairs
- $390,000 2024-01-18 00:00:00 Agency: Department of Veterans Affairs
- $194,435 2024-01-18 00:00:00 Agency: Department of Veterans Affairs
- $65,460 2023-10-05 00:00:00 Agency: Department of Veterans Affairs
- $48,609 2023-10-01 00:00:00 Agency: Department of Veterans Affairs
- $38,887 2023-07-20 00:00:00 Agency: Department of Veterans Affairs
- $25,200 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $67,200 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $33,220 2023-04-18 00:00:00 Agency: Department of Veterans Affairs
- $155,548 2023-04-14 00:00:00 Agency: Department of Veterans Affairs
- $8,400 2023-04-13 00:00:00 Agency: Department of Veterans Affairs
- $84,000 2023-04-07 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-04-07 00:00:00 Agency: Department of Veterans Affairs
- $70,000 2023-04-07 00:00:00 Agency: Department of Veterans Affairs
- $3,158 2023-04-06 00:00:00 Agency: Department of Veterans Affairs
- $32,406 2023-03-24 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-02-07 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-02-07 00:00:00 Agency: Department of Veterans Affairs
- $390,000 2023-02-07 00:00:00 Agency: Department of Veterans Affairs
- $194,435 2023-02-07 00:00:00 Agency: Department of Veterans Affairs
- $168,000 2023-02-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $96,960 2023-02-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $33,940 2022-08-11 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $32,900 2022-07-27 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $32,900 2022-06-13 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $9,768 2022-03-28 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $96,208 2022-03-15 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $83,358 2022-03-09 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $49,364 2021-07-21 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $70,021 2021-07-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $9,768 2021-04-30 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $34,519 2021-04-19 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $48,839 2021-03-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $36,501 2020-12-15 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $66,000 2020-12-04 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2020-06-25 Agency: DEPARTMENT OF DEFENSE (DOD)
- $47,956 2020-04-10 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of VCYT in WallStreetBets Daily Discussion
VCYT News
Recent insights relating to VCYT
CNBC Recommendations
Recent picks made for VCYT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in VCYT
VCYT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view VCYT Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More